Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05368571 · ClinicalTrials.gov registry record · NA
CHOICES-TEEN Randomized Controlled Trial
A NA study of HIV Risk and Risk for an Alcohol-Exposed Pregnancy, sponsored by University of Texas at Austin.
- Recruiting
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT05368571: Recruiting NA study of HIV Risk and Risk for an Alcohol-Exposed Pregnancy, sponsored by University of Texas at Austin.
NCT05368571 is a NA study of HIV Risk and Risk for an Alcohol-Exposed Pregnancy that is actively recruiting participants, run by University of Texas at Austin. The registered enrollment target is 400 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05368571, a NA study of HIV Risk and Risk for an Alcohol-Exposed Pregnancy, is actively recruiting participants, sponsored by University of Texas at Austin.
- RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized controlled trial will: 1) Test the efficacy of the CHOICES-TEEN (CT) intervention compared with an Attentional Control (AC) condition on reducing the risk of substance-exposed pregnancy (SEP) and HIV/STI among high-risk female youth involved with the juvenile justice system by reducing alcohol use, increasing marijuana cessation, reducing risk of pregnancy, and increasing condom use; 2) Test the efficacy of CT, compared to AC, on increasing cognitive self-regulation abilities; 3) Test proposed intervention mediators/mechanisms of action for CT overall and by race/ethnicity; and 4) Test the moderating effect of initial readiness to change on risk of SEP and risk of HIV/STI.
Primary Outcome
Risk of AEP is defined as any risk drinking (\>3 drinks/day or \>7 drinks/week on average) and any occurrence of vaginal sex with no use or ineffective use of contraception in the assessment period. Self-reported daily alcohol use (in standard drinks), vaginal intercourse, and contraception (effective use) data from the Timeline Followback will be used to calculate risk of AEP for the previous 90 days. Change in Risk of AEP will be examined at 3-, 6-, and 9-months post-intake. A participant will
Conditions Studied
Interventions
- OTHER CHOICES-TEEN
- OTHER Health and Life Skills Education
Study Locations (1)
Texas
- Baylor University - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2022-04-08 |
| Est. Completion | 2026-04-10 |
| Phase | NA |
What NCT05368571 shows while recruiting
NCT05368571 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).
The record links to 5 conditions, with HIV Risk appearing as the primary indexed condition, and to 2 interventions - of which CHOICES-TEEN is the first listed.
NCT05368571 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05368571 about?
NCT05368571 is a clinical study titled "CHOICES-TEEN Randomized Controlled Trial". This randomized controlled trial will: 1) Test the efficacy of the CHOICES-TEEN (CT) intervention compared with an Attentional Control (AC) condition on reducing the risk of substance-exposed pregnancy (SEP) and HIV/STI among high-risk female youth involved with the juvenile justice system by reduci...
What is the current status of trial NCT05368571?
This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2022-04-08. Estimated completion is 2026-04-10.
What conditions does trial NCT05368571 study?
This clinical trial studies the following conditions: HIV Risk, Risk for an Alcohol-Exposed Pregnancy, Risk for Marijuana-Exposed Pregnancy, Risk for Substance-Exposed Pregnancy, Sexually Transmitted Infection Risk.
What interventions are being tested in trial NCT05368571?
The interventions under investigation include: CHOICES-TEEN (OTHER), Health and Life Skills Education (OTHER).
Who is sponsoring clinical trial NCT05368571?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05368571 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Risk
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05368571's enrollment target sits among peer trials
400 246th of 2000 higher than 1,734 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI